BDBM50322485 (2S)-5-(3-aminophenylamino)-2-((4R)-4-((3R,7R,8R,9S,10S,13R,14S,17R)-3,7-dihydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanamido)-5-oxopentanoate::CHEMBL1170247

SMILES C[C@H](CCC(=O)N[C@@H](CCC(=O)Nc1cccc(N)c1)C(O)=O)[C@H]1CC[C@H]2[C@@H]3[C@H](O)C[C@H]4C[C@H](O)CC[C@]4(C)[C@H]3CC[C@]12C

InChI Key InChIKey=AYNNLJQUTJDIEG-BPBHNCSOSA-N

Data  1 KI

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 50322485   

TargetIleal sodium/bile acid cotransporter(Homo sapiens (Human))
University Of Maryland

Curated by ChEMBL
LigandPNGBDBM50322485((2S)-5-(3-aminophenylamino)-2-((4R)-4-((3R,7R,8R,9...)
Affinity DataKi:  1.63E+4nMAssay Description:Inhibition of human ASBT expressed in MDCK cells assessed as inhibition of [3H]taurocholic acid uptake after 10 mins by liquid scintillation countingMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed